I’ve said that several times but alot of newbie flippers that have no clue keep saying bad earning. People that need educated in biotech and how there value works.
$MYOV No worries. Anyone who expected a BIO to have a positive earnings report while still is in the development stage is fooling themselves. What's important are the drugs coming to market. That's where this company shines. MYOV will have FDA approval this year and that's when earnings drastically improve. Hold or sell, I don't care. In one year this will be double, triple, or higher!
View original message
  • 1